Elaboration of technology and comparative research of pellets of tamsulosin the modified liberation
https://doi.org/10.20538/1682-0363-2011-5-135-139
Abstract
The work purpose consisted in elaboration of technology of reception pellets of tamsulosin with the modified liberation, and also an estimation of their comparative bioequivalence with a comparison preparation. Their bioequivalence judged by results of treatment of rats with experimental good-quality hyperplasia of prostatic glands. By results of researches the structure and technology pellets of tamsulosin are proved, their bioequivalence with a comparison preparation is proved.
About the Authors
Ye. V. BlynskayaRussian Federation
N. A. Uvarov
Russian Federation
Ye. Ye. Lazareva
Russian Federation
V. K. Alexeyev
Russian Federation
References
1. Иремашвили В.В. Тамсулозин в комбинированной фармакотерапии симптомов нижних мочевых путей//Рос. мед. журн. 2009. ¹ 25. С. 49-52.
2. Проведение качественных исследований биоэквивалентности лекарственных средств: метод. указания (утв. Минз-дравсоцразвития). М., 2004. 47 с.
3. Dong Z., Wang Z., Yang K. et al. Tamsulosin versus terazosin for benign prostatic hyperplasia: a systematic review//Syst. Biol. Reprod. Med. 2009. V. 55, ¹ 4. P. 129-136.
4. Naslund M.J., Miner M. A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate//Clin. Ther. 2007. V. 29, ¹ 1. P. 17-25.
5. Ren R.M., Kou M., Lan X.X. Efficacy and safety of tamsulo-sin for the treatment of benign prostatic hyperplasia: a meta analysis//Chin. Med. J. 2010. V. 123, ¹ 2. P. 234-238.
Review
For citations:
Blynskaya Ye.V., Uvarov N.A., Lazareva Ye.Ye., Alexeyev V.K. Elaboration of technology and comparative research of pellets of tamsulosin the modified liberation. Bulletin of Siberian Medicine. 2011;10(5):135-139. (In Russ.) https://doi.org/10.20538/1682-0363-2011-5-135-139